Graham McLean Buys 1,000 Shares of Fisher & Paykel Healthcare Co. Limited (ASX:FPH) Stock

Fisher & Paykel Healthcare Co. Limited (ASX:FPH) insider Graham McLean purchased 1,000 shares of the business’s stock in a transaction on Monday, February 17th. The stock was purchased at an average cost of A$32.30 ($20.57) per share, with a total value of A$32,300.00 ($20,573.25).

Fisher & Paykel Healthcare Stock Performance

The firm has a market capitalization of $20.55 billion, a price-to-earnings ratio of 157.79, a P/E/G ratio of 4.47 and a beta of 0.42. The company has a debt-to-equity ratio of 10.75, a current ratio of 1.83 and a quick ratio of 0.79.

Fisher & Paykel Healthcare Increases Dividend

The firm also recently declared a Interim dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.167 per share. The ex-dividend date was Wednesday, December 4th. This represents a yield of 0.49%. This is an increase from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. Fisher & Paykel Healthcare’s payout ratio is currently 180.95%.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.